Markers of achievement for assessing and monitoring gender equity in translational research organisations: a rationale and study protocol.

BMJ Open

Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Oxford, UK NIHR Oxford Biomedical Research Centre, Joint Research Office, Churchill Hospital, Oxford, UK Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Published: January 2016

AI Article Synopsis

  • * This study evaluates gender equity support in the NIHR Biomedical Research Centres in Oxford and London, using a specially designed framework and metrics to measure progress over two funding periods (2007-2012 and 2012-2017).
  • * Findings will inform strategies to boost women's advancement in leadership roles and will be shared with academics and practitioners via conferences and peer-reviewed articles.

Article Abstract

Introduction: Translational research organisations (TROs) are a core component of the UK's expanding research base. Equity of career opportunity is key to ensuring a diverse and internationally competitive workforce. The UK now requires TROs to demonstrate how they are supporting gender equity. Yet, the evidence base for documenting such efforts is sparse. This study is designed to inform the acceleration of women's advancement and leadership in two of the UK's leading TROs--the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in Oxford and London--through the development, application and dissemination of a conceptual framework and measurement tool.

Methods And Analysis: A cross-sectional retrospective evaluation. A conceptual framework with markers of achievement and corresponding candidate metrics has been specifically designed for this study based on an adapted balanced scorecard approach. It will be refined with an online stakeholder consultation and semistructured interviews to test the face validity and explore practices and mechanisms that influence gender equity in the given settings. Data will be collected via the relevant administrative databases. A comparison of two funding periods (2007-2012 and 2012-2017) will be carried out.

Ethics And Dissemination: The University of Oxford Clinical Trials and Research Governance Team and the Research and Development Governance Team of Guy's and St Thomas' National Health Service (NHS) Foundation Trust reviewed the study and deemed it exempt from full ethics review. The results of the study will be used to inform prospective planning and monitoring within the participating NIHR BRCs with a view to accelerating women's advancement and leadership. Both the results of the study and its methodology will be further disseminated to academics and practitioners through the networks of collaborating TROs, relevant conferences and articles in peer-reviewed journals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716190PMC
http://dx.doi.org/10.1136/bmjopen-2015-009022DOI Listing

Publication Analysis

Top Keywords

gender equity
12
markers achievement
8
translational organisations
8
women's advancement
8
advancement leadership
8
conceptual framework
8
governance team
8
study
6
will
5
achievement assessing
4

Similar Publications

Background: Value-based care payment and delivery models such as the recently implemented Merit-based Incentive Payment System (MIPS) aim to both provide better care for patients and reduce costs of care. Gender disparities across orthopaedic surgery, encompassing reimbursement, industry payments, referrals, and patient perception, have been thoroughly studied over the years, with numerous disparities identified. However, differences in MIPS performance based on orthopaedic surgeon gender have not been comprehensively evaluated.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Multi-Ethnic Health Equity Research Center, University of California, San Francisco, San Francisco, CA, USA.

Background: Prior studies suggest that neighborhood socioeconomic status, neighborhood walkability, and neighborhood social cohesion are associated with cognitive function and dementia risk. However, little is known about how neighborhood social and built environments influence dementia risk in South Asian populations residing in the US.

Methods: We used data from 745 South Asian individuals ≥40 years in the US who completed Exam 2 (2015-2018) of the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

School of Psychology, Massey University, Palmerston North, Manawatu, New Zealand.

Background: Research identified individual-level socioeconomic factors as key determinants of cognitive health. This study investigated the effect of area-based socioeconomic deprivation on cognitive outcomes in midlife to early late-life New Zealanders without cognitive impairment. Understanding geographical dimensions of socioeconomic determinants of cognitive health is important from an equity perspective.

View Article and Find Full Text PDF

Background: Neighborhood conditions and their racial patterning represent under-studied factors that could contribute to racial disparities in dementia risk. Neighborhood socioeconomic status (SES) has been linked to dementia, but the racial distribution of SES within a neighborhood may also matter for dementia risk.

Method: Individual-level data from 460 (47% Black, 46% White, 7% other) older adults from the Michigan Cognitive Aging Project (Table 1) were linked to census tract-level data from the National Neighborhood Data Archive.

View Article and Find Full Text PDF

Background: Dementia is a complex condition that affects individuals in various ways around the world, with a particularly high prevalence and incidence in low- to middle-income countries. However, the majority of clinical trials on immunomodulators in Alzheimer's disease have predominantly been conducted in specific geographic regions and populations. Our objective is to assess the diversity and inclusiveness of the participant samples in terminated phase 2 or 3 clinical trials for anti-amyloid therapies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!